Journey Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Journey Medical Corporation (DERM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-14.67-3.85-29.63-43.995.28
Depreciation & Amortization3.523.774.372.561.52
Deferred Income Tax0.000.000.001.570.00
Stock Based Compensation6.102.614.432.470.15
Change in Working Capital-3.77-1.666.1914.71-2.23
Change in Accounts Receivable4.4812.55-5.380.77-5.02
Change in Inventory-4.233.951.74-8.46-0.55
Change in Accounts Payable-2.09-18.4214.3720.39-0.15
Change in Other Working Capital0.310.240.832.101.30
Other Operating Activities0.310.440.835.640.36
Net Cash from Operating Activities-9.135.24-13.53-2.185.13
Investing Activities
Capital Expenditures-15.005.00-20.0010.000.00
Sales/Maturities of Investments-15.00-5.00-20.00-10.00-1.20
Other Investing Activities0.000.000.00-10.000.00
Net Cash from Investing Activities-15.00-5.00-20.00-10.00-1.20
Financing Activities
Debt Repayment-1.25-51.95-7.86-11.49-0.50
Common Stock Issued8.294.620.1432.540.01
Other Financing Activities-0.05-0.47-0.59-3.550.00
Net Cash from Financing Activities16.99-4.8016.4653.02-0.49
Summary
Net Change in Cash-7.13-4.56-17.0840.843.45
Cash at Beginning of Period27.4432.0049.088.250.00
Cash at End of Period20.3146.3432.0049.080.00
Free Cash Flow-24.135.24-33.53-2.185.13
Supplemental Disclosures
Interest Paid2.011.130.990.000.00
Income Taxes Paid0.130.180.170.160.11